CAMP4 Therapeutics Corporation (CAMP) vs Protalix BioTherapeutics, Inc. (PLX)
- CAMP4 Therapeutics Corporation CAMP 3.17 −8.12%
- Protalix BioTherapeutics, Inc. PLX 2.62 −2.96%
CAMP4 Therapeutics Corporation and Protalix BioTherapeutics, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Protalix BioTherapeutics, Inc. are of similar size ($217.5M and $216.5M). CAMP4 Therapeutics Corporation has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.4×. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs −2,543.7%) and the higher return on invested capital (48.5% vs 0.00%). Across the 14 metrics below, Protalix BioTherapeutics, Inc. leads on 10 and CAMP4 Therapeutics Corporation on 4.
Valuation
Profitability
| Metric | CAMP | PLX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 69.20% | 65.16% |
| Operating margin | (1,254.22%) | 28.89% | 0.00% |
| Net margin | (2,543.74%) | 23.50% | 0.00% |
| Free cash flow margin | (680.36%) | 9.51% | 0.00% |
| Return on equity | (545.85%) | 31.23% | (56.36%) |
| Return on assets | (148.23%) | 20.07% | (48.04%) |
| Return on invested capital | 0.00% | 48.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack